NDA study for Mexico [Regulatives / Guidelines]

posted by jag009  – NJ, 2019-12-06 16:19 (519 d 16:19 ago) – Posting: # 20943
Views: 2,604


Does anyone have experience conducting NDA studies for ER products in Mexico? I mean running a study comparing ER once a day vs IR given multi-times a days, e.g, ER vs IR given every 4 hours. When conducting such studies, the success criteria is based on equivalent AUC (90% CI), and not Cmax due to the nature of the ER drug release kinetic.

I received a comment from the mexico regulatory when they reviewed the protocol. They wanted Cmax as an equivalent criteria as well but that is not my intention (I ran studies like this in US and usually this is not a problem at the protocol review stage).


Complete thread:

 Admin contact
21,445 posts in 4,482 threads, 1,510 registered users;
online 17 (0 registered, 17 guests [including 4 identified bots]).
Forum time: Sunday 09:38 CEST (Europe/Vienna)

It is better to know some of the questions
than all of the answers.    James Thurber

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz